Emerging evidence suggests a potential molecular link between AT and thyroid malignancies, characterized by the co-expression of multiple genes such as TSHR, BTB domain and CNC homolog 2 (BACH2), and forkhead box E1 (FOXE1), along with shared somatic mutations [6,40]. Here, FOXE1 is linked to thyroid gland disorder.